Technology

Diabetes technology section

Agamatrix Presto Blood Glucose Testing

Successful diabetes management starts with accurate numbers. WaveSense is a new technology that personalizes each test to provide world class accuracy. It detects and corrects for common sources of error that make blood glucose measurements inaccurate. Some of the common errors are:

Blood Samples - Blood sample variations such as hematocrit level (the amount of red blood cells in the sample) or chemical interferences from food or beverages (such as vitamin C from orange juice).

Debiotech Jewel Pump

Debiotech Jewel Pump

The Debiotech JewelPump is a disposable patch pump with some similarities to the current Omnipod, as well as other patch pumps on the horizon. Debiotech, a Swiss company, teamed with ST Microelectronics to create this sleek pump system. Like most patch pumps, a separate controller is required to deliver bolus insulin doses. It use a microelectromechanical (MEMS) pumping system, that allows the pump to be kept small and light.

Cellnovo Insulin Pump

The Cellnovo semi-patch pump (patch pump with a nearby infusion site) got a lot of attention in 2009 when it was first announced because of it's small size and iPhone like handset. Cellnovo, a London based company, has now joined forces with Osaka, Japan based Nipro Diagnostics, a blood glucose meter company, for integration of a meter into the Cell-Novo controller for the pod. We saw the pump at this year's ADA, but we were unable to handle it since it wasn't FDA approved yet.

Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump

Pearl Insulin Pump from Asante Solutions

SUNNYVALE, Calif., May 17, 2011 – Asante Solutions, Inc. (Asante), a medical device company focused on diabetes care, announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company's Pearl Insulin Pump. Last month, the Pearl also received the CE Mark, a European proof of conformity that certifies the product meets EU safety, health and environmental requirements. 

Solianis

The Swiss medical device company, Solianis, is developing products for physiological glucose monitoring, including a non-invasive, continuous glucose monitoring device. Based on impedance spectroscopy, their device uses radio waves and changes in skin resistance to monitor changes in blood composition. Solianis employs a multi-sensor approach to monitor various factors, including body temperature, microcirculation, sweat, moisture in the skin and the thickness of different skin layers as often as once a minute.

Pages

Subscribe to RSS - Technology